Skip to content

One-time Abutment Placement Versus 4 Times Abutment Removal Around Dental Implants

One-time Abutment Placement Versus 4 Times Abutment Removal on Interproximal Bone Levels and Peri-implant Soft Tissues: a Prospective Randomized Clinical Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05711147
Enrollment
43
Registered
2023-02-02
Start date
2017-12-01
Completion date
2023-12-31
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Prosthetic Abutment

Brief summary

Introduction: the repeated connection and disconnection of healing abutments during dental implants´ osseointegration has been associated with significant increased peri-implant bone loss, when compared with placing the final prosthetic abutment during implant placement surgery and non-removing it ever again. Previous data from animal studies suggests that the higher the number of removals of the healing abutments, the greater the bone resorption around implants, however the evidence in humans is scarce and heterogeneous. Furthermore, this greater bone resorption has been claimed to be associated to the inflammatory status of the peri-implant soft tissues, which would be greater as a consequence of the repeated disruption of the soft-tissues attachment to the prosthetic abutment, and the hypothetical microbial contamination of the implant-abutment interphase, induced by the repeated manipulation of the prosthetic components. Objective: to evaluate the changes in peri-implant crestal bone levels between two prosthetic protocols, the control being the conventional protocol where healing abutments are placed during surgery and removed four times before the delivery of the final abutment and prostheses, and the test protocol where definitive abutments are placed immediately after implant placement and are not removed ever again. Material and methods: 80 platform switched implants will be placed in the posterior maxilla or mandible of 40 partial edentulous patients. Immediately after implant placement, patients will be randomized to receive the definitive abutment at the moment of implant placement (one abutment-one time protocol), or 12 weeks later, after removing the healing abutment four times during the confection of the final prostheses, following the conventional protocol for implant supported restorations. The day of prostheses delivery, a mucosal biopsy from the implant surrounding tissues will be taken for histomorphometric and immunohistochemical analyses of the inflammatory response of the peri-implant soft tissues. Radiographic assessment of vertical bone level changes (primary outcome), clinical status of peri-implant tissues, changes in soft tissues margin, patient related outcomes and adverse events will be assessed at 6, 12, 24 and 36 months after loading.

Interventions

PROCEDUREAbutment removal

4 times healing abutment removal during prosthesis making (impressions, metal try-in, ceramic try-in, prosthesis loading)

PROCEDUREPlacement of definitive abutment

Placement of the final prosthetic abutment at the moment of implantation

Sponsors

Camlog Oral Reconstruction Foundation
CollaboratorOTHER
Universidad Complutense de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least two adjacent missing teeth in the posterior maxilla or mandible (positions 4 to 7) * Willing to receive implant supported fixed partial dentures * There must be a natural tooth mesial to the most proximal implant site, however free end situations will be allowed for the distal implants * Healed sites (minimum 12 weeks post-extraction) * In the case of prior bone augmentation, a minimum of 6 months of healing is required * Simultaneous bone augmentation will be allowed only for close sinus lifting

Exclusion criteria

Systemic

Design outcomes

Primary

MeasureTime frameDescription
Changes in interproximal bone levelsImplantation, prosthesis loading, 6 months, 12 months, 24 months, 36 monthsChanges at the mesial and distal crestal bone levels measured in periapical digital radiographs at the mesial and distal implant aspects

Secondary

MeasureTime frameDescription
Keratinized peri-implant mucosaProsthesis loading, 6 months, 12 months, 24 months, 36 monthsPresence or absence of keratinized peri-implant mucosa in the mid-buccal and mid-lingual aspects
Modified plaque indexProsthesis loading, 6 months, 12 months, 24 months, 36 monthsModified plaque index (Mombelli et al. 1987) at six sites per implant
Sulcus bleeding indexProsthesis loading, 6 months, 12 months, 24 months, 36 monthsSulcus bleeding index (Mombelli et al. 1987) at six sites per implant
Probing depthProsthesis loading, 6 months, 12 months, 24 months, 36 monthsProbing depth (Mombelli et al. 1987) at six sites per implant
Clinical crown length of the adjacent toothProsthesis loading, 6 months, 12 months, 24 months, 36 monthsCLT: distance in mm from the highest line of gingival/mucosal curvature of the crown to the occlusal aspect of the tooth
MobilityProsthesis loading, 6 months, 12 months, 24 months, 36 monthsImplant and/or prostheses mobility
Papilla indexProsthesis loading, 6 months, 12 months, 24 months, 36 monthsIP: distance in mm from the top of the mesial and distal papillae of each implant to the most coronal portion of the contact point or the occlusal surface (Grunder 2000)
Patient-reported outcomesProsthesis loading, 6 months, 12 months, 24 months, 36 months5-items questionnaire (comfort, appearance, masticatory function, taste and overall satisfaction) rated according to the following scale: very unsatisfied, unsatisfied, fair, satisfied, and very satisfied
Adverse eventsProsthesis loading, 6 months, 12 months, 24 months, 36 monthsOccurrence and nature of adverse events, either implant or prostheses associated (device related adverse events and other tissue complications), or non-implant associated (death, serious illness or any condition requiring hospitalization for more than 1 day).
Hystomorphometric analysis of soft tissue biopsy samplesProsthesis loadingTotal areas of the sample, the epithelium, the connective tissue, the inflammatory infiltrate and cell density in an interest area into the inflammatory infiltrate
Immunohistochemical analysis of the histologic sectionsProsthesis loadingNature and extension of the inflammatory infiltrate in the connective tissue: high positive (HP), positive (P), low positive (LP) or negative (N) staining
Clinical crown length of the implant supported crownProsthesis loading, 6 months, 12 months, 24 months, 36 monthsCLI: distance in mm from the highest line of mucosal curvature of the crown to the occlusal aspect of the implant prostheses

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026